SUSQUEHANNA INTERNATIONAL GROUP, LLP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 163 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,612,010
-20.5%
78,673
-23.0%
0.00%
Q2 2023$2,028,906
-23.9%
102,109
-34.4%
0.00%
Q1 2023$2,667,449
+39.0%
155,718
+58.8%
0.00%
Q4 2022$1,919,367
-53.4%
98,077
-62.0%
0.00%
-100.0%
Q3 2022$4,115,000
+734.7%
257,841
+619.1%
0.00%
Q2 2022$493,000
-55.8%
35,854
-49.1%
0.00%
Q1 2022$1,116,000
-60.6%
70,394
-45.8%
0.00%
Q4 2021$2,836,000
-17.6%
129,934
+12.9%
0.00%
Q3 2021$3,440,000
-42.0%
115,092
-14.1%
0.00%
-100.0%
Q2 2021$5,933,000
-53.0%
133,943
-52.9%
0.00%
-50.0%
Q1 2021$12,622,000
-60.5%
284,484
-51.2%
0.00%
-33.3%
Q4 2020$31,950,000
+5667.1%
582,594
+2302.3%
0.00%
Q3 2020$554,000
-12.9%
24,252
-20.2%
0.00%
Q2 2020$636,000
+12.0%
30,400
-25.3%
0.00%
Q1 2020$568,000
-28.7%
40,691
+16.3%
0.00%
Q4 2019$797,000
+4.3%
35,000
-46.7%
0.00%
Q3 2019$764,000
-92.3%
65,626
-90.1%
0.00%
-100.0%
Q2 2019$9,943,000
+305.3%
662,640
+373.7%
0.00%0.0%
Q1 2019$2,453,000
+961.9%
139,900
+1388.3%
0.00%
Q3 2018$231,000
+5.0%
9,400
-16.1%
0.00%
Q2 2018$220,000
-77.9%
11,200
-78.9%
0.00%
Q1 2018$994,00053,0000.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,812,491$234,534,00010.10%
TANG CAPITAL MANAGEMENT LLC 2,965,485$41,369,0005.81%
Ghost Tree Capital, LLC 650,000$9,068,0002.40%
Boxer Capital, LLC 1,466,051$20,451,0001.39%
Vivo Capital, LLC 860,648$12,006,0001.09%
Samsara BioCapital, LLC 128,197$1,788,0001.03%
Cormorant Asset Management, LP 1,568,550$21,881,0001.02%
Perceptive Advisors 2,189,010$30,537,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,677,367$23,399,0000.74%
Eventide Asset Management 1,415,000$19,739,0000.64%
View complete list of ROCKET PHARMACEUTICALS INC shareholders